JP2005511038A5 - - Google Patents

Download PDF

Info

Publication number
JP2005511038A5
JP2005511038A5 JP2003548768A JP2003548768A JP2005511038A5 JP 2005511038 A5 JP2005511038 A5 JP 2005511038A5 JP 2003548768 A JP2003548768 A JP 2003548768A JP 2003548768 A JP2003548768 A JP 2003548768A JP 2005511038 A5 JP2005511038 A5 JP 2005511038A5
Authority
JP
Japan
Prior art keywords
factor viii
human factor
modified human
seq
substitutions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2003548768A
Other languages
English (en)
Japanese (ja)
Other versions
JP2005511038A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2002/037884 external-priority patent/WO2003047507A2/en
Publication of JP2005511038A publication Critical patent/JP2005511038A/ja
Publication of JP2005511038A5 publication Critical patent/JP2005511038A5/ja
Pending legal-status Critical Current

Links

JP2003548768A 2001-11-30 2002-11-27 第viii因子c2ドメインのバリアント Pending JP2005511038A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33456901P 2001-11-30 2001-11-30
PCT/US2002/037884 WO2003047507A2 (en) 2001-11-30 2002-11-27 Factor viii c2 domain variants

Publications (2)

Publication Number Publication Date
JP2005511038A JP2005511038A (ja) 2005-04-28
JP2005511038A5 true JP2005511038A5 (https=) 2005-12-22

Family

ID=23307813

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2003548768A Pending JP2005511038A (ja) 2001-11-30 2002-11-27 第viii因子c2ドメインのバリアント

Country Status (8)

Country Link
US (1) US20040249134A1 (https=)
EP (1) EP1456235A4 (https=)
JP (1) JP2005511038A (https=)
CN (1) CN1630666A (https=)
AU (1) AU2002364509A1 (https=)
CA (1) CA2462966A1 (https=)
MX (1) MXPA04005079A (https=)
WO (1) WO2003047507A2 (https=)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6458563B1 (en) * 1996-06-26 2002-10-01 Emory University Modified factor VIII
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
WO2005017149A1 (en) 2003-06-03 2005-02-24 Cell Genesys, Inc. Compositions and methods for enhanced expression of recombinant polypeptides from a single vector using a peptide cleavage site
US7485291B2 (en) 2003-06-03 2009-02-03 Cell Genesys, Inc. Compositions and methods for generating multiple polypeptides from a single vector using a virus derived peptide cleavage site, and uses thereof
US20050123997A1 (en) * 2003-10-30 2005-06-09 Lollar John S. Modified fVIII having reduced immunogenicity through mutagenesis of A2 and C2 epitopes
DK1750733T3 (da) * 2004-05-03 2014-01-20 Univ Emory FREMGANGSMÅDE TIL INDGIVELSE AF SVINE-B-DOMÆNELØS fVIII
MY185597A (en) * 2005-09-20 2021-05-24 Avantor Performance Mat Inc Vegetarian protein a preparation and methods thereof
FR2913020B1 (fr) * 2007-02-23 2012-11-23 Biomethodes Nouveaux facteurs viii pour le traitement des hemophiles de type a
IT1394522B1 (it) 2009-01-09 2012-07-05 Invatec Technology Ct Gmbh Dispositivo medicale con rilascio di farmaco
WO2011060242A2 (en) 2009-11-13 2011-05-19 Talecris Biotherapeutics, Inc. Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
EP2498803A4 (en) * 2009-11-13 2013-05-15 Puget Sound Blood Ct FACTOR VIII CELL EPITOPARIANTS WITH REDUCED IMMUNOGENITY
JP6042335B2 (ja) * 2010-09-15 2016-12-14 ノヴォ ノルディスク アー/エス 細胞取込みが低下した第viii因子変異体
DK2635297T3 (da) 2010-11-05 2019-05-06 Baxalta GmbH En ny variant af antihæmofil faktor viii, der har en øget specifik aktivitet
CA2940127A1 (en) * 2014-02-19 2015-08-27 Bloodworks Factor viii b cell epitope variants having reduced immunogenicity
WO2015132724A1 (en) 2014-03-05 2015-09-11 Pfizer Inc. Improved muteins of clotting factor viii
WO2025164792A1 (ja) * 2024-02-02 2025-08-07 学校法人自治医科大学 高比活性/高分泌発現型の第viii因子改変体、高発現型の第viii因子コード核酸及びそれらの用途

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4757006A (en) * 1983-10-28 1988-07-12 Genetics Institute, Inc. Human factor VIII:C gene and recombinant methods for production
US4965199A (en) * 1984-04-20 1990-10-23 Genentech, Inc. Preparation of functional human factor VIII in mammalian cells using methotrexate based selection
ES8801674A1 (es) * 1985-04-12 1988-02-16 Genetics Inst Un procedimiento para la preparacion de una proteina que presenta actividad procoagulante.
US5004803A (en) * 1988-11-14 1991-04-02 Genetics Institute, Inc. Production of procoagulant proteins
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5744446A (en) * 1992-04-07 1998-04-28 Emory University Hybrid human/animal factor VIII
US5663060A (en) * 1992-04-07 1997-09-02 Emory University Hybrid human/animal factor VIII
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US6180371B1 (en) * 1996-06-26 2001-01-30 Emory University Modified factor VIII
US6376463B1 (en) * 1992-04-07 2002-04-23 Emory University Modified factor VIII
US5364771A (en) * 1992-04-07 1994-11-15 Emory University Hybrid human/porcine factor VIII
US6458563B1 (en) * 1996-06-26 2002-10-01 Emory University Modified factor VIII
PL206105B1 (pl) * 2000-09-19 2010-07-30 Emory Universityemory University Zmodyfikowany ludzki czynnik VIII oraz sposób modyfikacji ludzkiego czynnika VIII ze zmniejszeniem reaktywności na przeciwciało hamujące i zachowaniem aktywności prokoagulacyjnej

Similar Documents

Publication Publication Date Title
JP2005511038A5 (https=)
JP2004525608A5 (https=)
Arai et al. Amino‐acid sequence of feather keratin from fowl
Benedetti X‐ray crystallography of peptides: The contributions of the Italian laboratories
RU2003107100A (ru) Модифицированный фактор viii
JP2018510622A5 (https=)
CZ286889B6 (en) Parathormone derivatives and pharmaceutical preparations in which they are comprised
Mtwisha et al. HSP 12 is a LEA-like protein in Saccharomyces cerevisiae
KR950704486A (ko) 성분b로 명명된 신규 단백질(new protein from urine named component b)
RU2006105498A (ru) Полипептиды для индукции защитного иммунного ответа против staphylococcus aureus
ATE509943T1 (de) Peptidreinigung mittels metallionenaffinitätschromatographie
US4659694A (en) Prothymosin alpha
JP2020517260A5 (https=)
WO2002008426A3 (en) Fh-binding protein of streptococcus pneumoniae
JP2008521795A5 (https=)
Vuilleumier et al. Synthetic peptide and template‐assembled synthetic protein models of the hen egg white lysozyme 87–97 helix: Importance of a protein‐like framework for conformational stability in a short peptide sequence
Browning et al. Disulfide scrambling of interleukin-2: HPLC resolution of the three possible isomers
WO2004014937A3 (en) Thrombin peptide derivatives
EP2046814A2 (en) Minimized small peptides with high affinity for factor viii and factor viii-like proteins
JP2004505640A5 (https=)
WO2001027136A3 (fr) Peptides ayant une activite de stimulation de la reponse immunitaire et de regeneration tissulaire
WO2003090667A3 (fr) Composition immunogene ou vaccinale non immunosuppressive, comprenant une proteine e7 mutee du virus hpv-16
CA2522329A1 (en) Inhibitors of coronavirus
JP2003334088A5 (https=)
US20090215025A1 (en) Small peptidic and peptido-mimetic affinity ligands for factor viii and factor viii-like proteins